Jim Simons Dr Reddys Laboratories LTD Transaction History
Renaissance Technologies LLC
- $63.1 Billion
- Q3 2024
A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Renaissance Technologies LLC holds 1,950,449 shares of RDY stock, worth $27.9 Million. This represents 0.25% of its overall portfolio holdings.
Number of Shares
1,950,449
Previous 1,995,495
2.26%
Holding current value
$27.9 Million
Previous $152 Million
1.93%
% of portfolio
0.25%
Previous 0.27%
Shares
24 transactions
Others Institutions Holding RDY
# of Institutions
244Shares Held
23.1MCall Options Held
12.7KPut Options Held
6.1K-
Morgan Stanley New York, NY2.24MShares$32.1 Million0.01% of portfolio
-
Robeco Institutional Asset Management B.V.2.07MShares$29.6 Million0.33% of portfolio
-
Royal Bank Of Canada Toronto, A62MShares$28.6 Million0.03% of portfolio
-
Black Rock Inc. New York, NY1.8MShares$25.8 Million0.0% of portfolio
-
Aikya Investment Management LTD London, X01.09MShares$15.6 Million9.6% of portfolio
About DR REDDYS LABORATORIES LTD
- Ticker RDY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 166,028,992
- Market Cap $2.38B
- Description
- Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...